TSS
XBIO icon

Two Sigma Securities’s Xenetic Biosciences XBIO Stock Holding History

Two Sigma Securities’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,022
Closed -$8.21K – 3425
2023
Q1 		$8.21K Buy
+2,022
New +$9.81K ﹤0.01% 2483
2022
Q4 		– Sell
-1,396
Closed -$8K – 3345
2022
Q3 		$8K Buy
+1,396
New +$11K ﹤0.01% 2433
2022
Q1 		– Sell
-1,404
Closed -$18K – 2563
2021
Q4 		$18K Buy
+1,404
New +$22.4K ﹤0.01% 1425
2021
Q1 		– Sell
-3,201
Closed -$65K – 1828
2020
Q4 		$65K Buy
+3,201
New +$38.7K ﹤0.01% 1543

Other funds holding XBIO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NC
NewSquare Capital Newtown Square, Pennsylvania $1.35B AUM 34.37% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Two Sigma Securities's XBIO Position: Q2 2023 in Review

Two Sigma Securities sold out of Xenetic Biosciences (XBIO) in Q2 2023, closing a stake of 2,022 shares — an estimated $8.21K sold.

Two Sigma Securities first reported a position in XBIO in Q4 2020 and held it in 4 quarters. The position peaked at $65K in Q4 2020. 9 funds tracked by Wall St. Rank hold XBIO as of Q2 2023.

  • Two Sigma Securities reported no remaining Xenetic Biosciences position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Securities sold 2,022 Xenetic Biosciences shares in Q2 2023, an estimated $8.21K.
  • Two Sigma Securities first reported a position in Xenetic Biosciences in Q4 2020 and held it in 4 quarters.
  • Two Sigma Securities's Xenetic Biosciences position peaked at $65K in Q4 2020.
  • 9 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q2 2023.

Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.